Bevacizumab (BV) maintenance (M) after first-line chemotherapy (CT) plus BV for metastatic colorectal cancer (mCRC) patients (pts): A meta-analysis of individual pts data (IPD) from three phase III studies

Category Systematic review
JournalJournal of Clinical Oncology
Year 2019
This article has no abstract
Epistemonikos ID: 97ee59890441757a76ec3107b22a61804cab8572
First added on: Feb 11, 2025